***All names are listed in alphabetical order.
| Thursday, 18 June 2026 | ||
|---|---|---|
| 14:45 - 15:10 | Opening & Introduction | |
| Mesrure Köseoğlu, Nikolaos Grigoriadis, Serkan Özben | ||
| 15:10 - 17:00 | Session 1: Neuroimmunology Across Borders: Regional Data and Challenges | |
| Chairs: Aysun Ünal, Ivan Milanov, Mesrure Köseoğlu, Nikolaos Grigoriadis, Serkan Özben | ||
| 15:10 - 15:20 | Session Overview and Objectives | Aysun Ünal |
| 15:20 - 16:50 | National Neuro-Immunology Data Insights Short country-based presentations highlighting key data and current trends |
Melih Tütüncü Nikolaos Grigoriadis Altın Kuqo Enra Suljić Mehmedika Jelena Drulović Ljiljana Radulovic Mario Habek Nevena Kamenova Rodica Ioana Bălaşa Tatjana Petkovska Boshkova |
| 16:50 - 17:00 | Closing Discussion and Common Themes | |
| 17:00 - 17:20 | COFFEE BREAK | |
| 17:20 - 18:40 | Session 2: MS Spectrum: From Immune Heterogeneity to Progression | |
| Chairs: Ivan Milanov, Murat Terzi, Rana Karabudak | ||
| 17:20 - 17:40 | Multiple Sclerosis: a disease or syndrome? | Ayşe Altıntaş |
| 17:40 - 18:00 | Revisiting MS Diagnosis: New Criteria and Early Diagnosis Challenges | Jelena Drulović |
| 18:00 - 18:20 | Neurorehabilitation in MS: The Contemporary Paradigm | Dimitar Maslarov |
| 18:20 - 18:40 | Moderated Discussion Moderator: Rana Karabudak Session Fellows: Caner Baydar, Yasemin Ekmekyapar Fırat |
Panelists: Nikolay Lazarov Topalov Tuncay Gündüz |
| Friday, 19 June 2026 | ||
|---|---|---|
| 08:00 - 09:00 | Abstract Sessions: Oral & Poster Presentations | |
| Moderators | ||
| Hall A | Ahmet Kasım Kılıç, Şeyda Figül Gökçe | |
| Hall B | Ferah Kızılay, Ufuk Aluçlu | |
| Hall C | Mustafa Açıkgöz, Selma Aksoy | |
| 09:00 - 10:10 | Session 3: Neuroimaging: Bridging Clinical Insight and Radiological Patterns | |
| Chairs: Constantinos Vadikolias, Hüsnü Efendi, Ljiljana Radulovic | ||
| 09:00 - 09:20 | Clinical Pitfalls at the Bedside: Real-Life Challenges in Differentiating MS, NMOSD, and MOGAD |
Yeşim Beckmann |
| 09:20 - 09:40 | Pattern-Based MRI Diagnosis: Imaging Features That Truly Guide Clinical Decision-Making |
Rana Karabudak |
| 09:40 - 10:10 | Case Discussion Moderator: Hüsnü Efendi Session Fellows: Bedriye Karaman, Pınar Acar Özen |
Case Presenters: Cihat Uzunköprü Coşkun Kerala Panelists: Mustafa Fazıl Gelal Stefanos Finitsis |
| 10:10 - 11:40 | Session 4: Neuro-Ophthalmic Disorders: Clinical and Radiological Decision Making | |
| Chairs: İpek Midi, Nilüfer Kale İçen, Rodica Ioana Bălaşa | ||
| 10:10 - 10:30 | Acute Optic Neuritis: Real-World Diagnostic Strategy | Joao Lemos |
| 10:30 - 10:50 | MRI Patterns That Change Management in Optic Neuropathies | Efrosini Papadaki |
| 10:50 - 11:10 | Red Flags - When Vision Loss Means Something More | Tülay Kansu |
| 11:10 - 11:20 | OCT and Angio-OCT in multiple sclerosis | Silviya Cherninkova |
| 11:20 - 11:40 | Case Discussion Moderator: Nilüfer Kale İçen Session Fellows: Abdulkadir Tunç, Rabia Koç |
Case Presenters: Eser Buluş Serkan Emekli Panelists: Kadriye Ağan Yıldırım |
| 11:40 - 12:00 | COFFEE BREAK | |
| 12:00 - 13:00 | Session 5: Plenary Lecture : Autoimmune Encephalitis | |
| Chairs: Murat Kürtüncü, Sashka Zhelyazkova | ||
| 12:00 - 12:45 | Antibody-Mediated Encephalitides as Individual Disorders: Multidisciplinary Implications Based on Immune Targets. | Josep Dalmau |
| 12:45 - 13:00 | Q&A Session Fellows: Bengü Altunan, Mehmet Demir |
|
| 13:00 - 14:00 | Lunch | |
| 14:00 - 15:10 | Session 6: MS Therapeutic targets update: B cells, microglia and oligodendrocytes | |
| Chairs: Ayşe Sağduyu Kocaman, Eva Kesidou, Gülşen Akman | ||
| 14:00 - 14:20 | B Cell Depletion and Beyond: Therapeutic Implications in MS | Panos Stathopoulos |
| 14:20 - 14:40 | Microglial Activation and Its Role as a Therapeutic Target in MS | Domna Karagogeos |
| 14:40 - 15:00 | Oligodendrocyte Biology and Remyelination Strategies in MS | Nikolaos Grigoriadis |
| 15:00 - 15:10 | Q&A Session Fellows: Duygu Arslan Mehdiyev, Meryem Tuba Sönmez |
|
| 15:10 - 16:40 | Session 7: The Immunotherapy Era: Oncologic Indications and Neurological Complications | |
| Chairs: Cem Ar, Dimitrios Dionysopoulos, Uğur Uygunoğlu | ||
| 15:10 - 15:30 | What is neuro-oncology and why should a neurologist consider it? | Evangelia Razis |
| 15:30 - 15:50 | Immune Effector Cell Therapies (CAR-T, TIL): Mechanisms of Action and Clinical Indications | Evdoxia Hatjiharissi |
| 15:50 - 16:10 | Glioma: Diagnosis, Treatment, and Guidance by Neurologists | Mathijs van der Meulen |
| 16:10 - 16:40 | Moderated Discussion Moderator: Uğur Uygunoğlu Session Fellows: Bade Güleç, Damla Çetinkaya Tezer |
Panelists: Cem Ar Dimitrios Dionysopoulos Merve Hazal Ser |
| 16:40 - 17:00 | COFFEE BREAK | |
| 17:00 - 18:15 | Session 8: Keynote Lecture: Behçet's Disease - Systemic and Neurological Management | |
| Chairs: Uğur Uygunoğlu | ||
| 17:00 - 17:30 | Systemic Behçet Disease An Overview of Pathogenesis and Multisystem Involvement |
Thedoros Xenitidis |
| 17:30 - 18:00 | Neuro-Behçet Disease Neurological Phenotypes, Diagnostic Challenges, and Management Strategies |
Aksel Siva |
| 18:00 - 18:15 | Q&A Session Fellows: Burcu Karpuz Seren, Keriman Oğuz |
|
| Saturday, 20 June 2026 | ||
|---|---|---|
| 08:00 - 09:00 | Abstract Sessions: Oral & Poster Presentations | |
| Moderators | ||
| Hall A | Gülnür Tekgöl, Özgül Ekmekçi | |
| Hall B | Gürdal Orhan, Semra Mungan | |
| Hall C | Tahir Kurtuluş Yoldaş, Yılmaz İnanç | |
| 09:00 - 10:30 | Session 9: Biomarkers in Autoimmune Neurology: From Laboratory to Clinical Practice | |
| Chairs: Ayşe Nur Yüceyar, Enra Mehmedika Suljic, Tatjana Petkovska Boshkova | ||
| 09:00 - 09:20 | Modern CSF Interpretation: OCB, Kappa Index, and Quantitative Immune Markers |
Zafeiris Tsinaris |
| 09:20 - 09:40 | Autoantibody Testing in CNS Demyelinating Pathologies: Accuracy, Pitfalls, and Clinical Value |
Atay Vural |
| 09:40 - 10:00 | OCT and Visual Pathway Damage in CNS Autoimmune Diseases | Friedemann Paul |
| 10:00 - 10:30 | Moderated Discussion Moderator: Erdem Tüzün Session Fellows: Gülgün Uncu, Sami Ömer Hoca |
Panelists: Charis Alexopoulos Gökçen Gözübatık Çelik |
| 10:30 - 10:50 | COFFEE BREAK | |
| 10:50 - 12:00 | Session 10: Infection and Immunity: Post-Infectious Neurological Complications | |
| Chairs: Ayşe Sağduyu Kocaman, Ioannis Iliopoulos, M.V.Padma Srivastava | ||
| 10:50 - 11:10 | Autoimmunity caused by systemic infections | Murat Akova |
| 11:10 - 11:30 | Post infectious autoimmune neurological complications | Nikolaos Grigoriadis |
| 11:30 - 12:00 | Case Discussion Moderator: Ayşe Sağduyu Kocaman Session Fellows: Ali Özhan Sıvacı, Nazlı Gamze Bülbül |
Case Presentations: Dragan Cibrev Katerina Varka Panelists: Canan Yücesan Meral Seferoğlu |
| 12:00 - 13:00 | INDUSTRY SUPPORTED SESSION | |
| 13:00 - 14:00 | LUNCH | |
| 14:00 - 15:20 | Session 11: Muscle and Neuromuscular Junction – Optimization in Clinical Practice. | |
| Chairs:Blerim Myftiu, Nejdet Karlı, Ufuk Emre Toprak | ||
| 14:00 - 14:20 | Inflammatory Myopathies: Update on Pathogenesis, Diagnosis, and Therapy | Piraye Oflazer |
| 14:20 - 14:40 | Management of Refractory MG: When Standard Therapies Fail | Ivailo Tournev |
| 14:40 - 15:00 | Precision Immunology in Myasthenia Gravis: From Mechanisms to Targeted Therapies | Hacer Durmuş Tekçe |
| 15:00 - 15:20 | Early experience with FcRn inhibitors in Myasthenia Gravis - clinical insights from Bulgaria | Dimitar Taskov - Izabel Antova |
| 15:20 - 15:50 | Case Discussion Moderators: Necdet Karlı Session Fellow: Emel Oğuz Akarsu, Nedim Ongun |
Case Presentations: Ayça Gül Güngördü Pınar Özçelik Panelists: Ayşe Çağlar Sarılar Sezin Alpaydın Baslo |
| 15:50 - 16:10 | COFFEE BREAK | |
| 16:10 - 17:40 | Session 12: Peripheral Nerve – Challenging Immune Mediated Neuropathies | |
| Chairs: Füsun Mayda Domaç, Nurten Adatepe Uzun | ||
| 16:10 - 16:30 | CIDP: Evolving Diagnostic Criteria, Clinical Variants, and Treatment Strategies | Yeşim Parman |
| 16:30 - 16:50 | Beyond CIDP: Autoimmune Nodopathies and Inflammatory Mimics | Ebru Can Kurt |
| 16:50 - 17:10 | Paraproteinemic and Paraneoplastic Neuropathies: A Multidisciplinary Perspective | Panayotis Zis |
| 17:10 - 17:40 | Moderated Discussion Moderator: Ayşegül Gündüz Session Fellows: Berin İnan, Doruk Arslan |
Panelists: Arman Çakar Ayşe Münife Neyal |
| 17:40 - 18:50 | Session 13: The Complement System in Neuroimmunology: From Mechanisms to Clinical Decisions | |
| Chairs: Alev Leventoğlu, Mario Habek, Sibel Canbaz Kabay | ||
| 17:40 - 18:00 | Complement Activation in Autoimmune Neurology Pathophysiology and Clinical Relevance |
Elma Evangelopoulos |
| 18:00 - 18:20 | Complement-Targeted Therapies in Neuroimmune Diseases Current Approaches in MG and NMOSD |
Meryem Aslı Tuncer |
| 18:20 - 18:50 | Moderated Discussion Moderator: Sibel Canbaz Kabay Session Fellows: Hazal Ceren Manazoğlu, Melike Ercan |
Panelist: Emine Belgin Koçer |
| Sunday, 21 June 2026 | ||
|---|---|---|
| 08:30 - 09:30 | Abstract Sessions: Oral & Poster Presentations | |
| Moderators | ||
| Hall A | Bilgin Öztürk, Funda Uysal Tan | |
| Hall B | Dürdane Aksoy, Saltanat Mert | |
| Hall C | Mustafa Çam, Fatma Kurtuluş | |
| 09:30 - 11:00 | Session 14: Women's Health and Lifestyle Factors in Autoimmune Neurology | |
| Chairs: Gençer Genç, Serpil Demirci, Yusuf Taman | ||
| 09:30 - 09:50 | Pregnancy Planning and Treatment Optimization in MS | Münire Kılınç |
| 09:50 - 10:10 | Obesity, Metabolism, and Immune Modulation: Emerging Roles of GLP-1 Receptor Agonists ? | Meral Mert |
| 10:10 - 10:30 | The Role of Sleep in the Pathophysiology of Autoimmune Disorders and Multiple Sclerosis | Gülçin Benbir Şenel |
| 10:30 - 11:00 | Case Discussion Moderator: Gençer Genç Session Fellows: Esra Taşkıran, Zeynep Özdemir |
Case Presenters: Nikolaos Mitsoudis Sena Destan Bünül Panelists: Özlem Taşkapılıoğlu Selma Šabanagić-Hajrić |
| 11:00 - 11:10 | Closing Remarks - Aysun Ünal, Mesrure Köseoğlu, Nikolaos Grigoriadis, Serkan Özben | |
| 11:10 - 13:00 | Roundtable Session: Founding Meeting: Building a Regional Neuroimmunology Network (Closed) | |
| Moderator: Aysun Ünal, Mesrure Köseoğlu, Serkan Özben | ||
| Proposal of joint multicenter datasets and future collaborations | ||
| Proposal for future real word clinical multicenter studies | Bengü Altunan - Mehmet Demir - Mehmet Fatih Yetkin - Mesude Tütüncü | |